69 related articles for article (PubMed ID: 27038038)
1. Corrigendum.
Biol Cell; 2016 Apr; 108(4):113. PubMed ID: 27038038
[TBL] [Abstract][Full Text] [Related]
2. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
Fornari F; Gramantieri L; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Giovannini C; Croce CM; Bolondi L; Negrini M
Oncogene; 2008 Sep; 27(43):5651-61. PubMed ID: 18521080
[TBL] [Abstract][Full Text] [Related]
3. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma.
Kongkavitoon P; Tangkijvanich P; Hirankarn N; Palaga T
PLoS One; 2016; 11(1):e0146696. PubMed ID: 26766040
[TBL] [Abstract][Full Text] [Related]
5. Radiosurgery inhibition of the Notch signaling pathway in a rat model of arteriovenous malformations.
Tu J; Li Y; Hu Z; Chen Z
J Neurosurg; 2014 Jun; 120(6):1385-96. PubMed ID: 24410155
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of p57 accelerates the growth and invasion of hepatocellular carcinoma.
Guo H; Lv Y; Tian T; Hu TH; Wang WJ; Sui X; Jiang L; Ruan ZP; Nan KJ
Carcinogenesis; 2011 Dec; 32(12):1897-904. PubMed ID: 22002319
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavage.
Xu J; Yun X; Jiang J; Wei Y; Wu Y; Zhang W; Liu Y; Wang W; Wen Y; Gu J
Hepatology; 2010 Jul; 52(1):142-54. PubMed ID: 20578140
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus X protein activates Notch signaling by its effects on Notch1 and Notch4 in human hepatocellular carcinoma.
Gao J; Xiong Y; Wang Y; Wang Y; Zheng G; Xu H
Int J Oncol; 2016 Jan; 48(1):329-37. PubMed ID: 26530164
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling.
Suwanjunee S; Wongchana W; Palaga T
Anticancer Drugs; 2008 Jun; 19(5):477-86. PubMed ID: 18418214
[TBL] [Abstract][Full Text] [Related]
10. Notch1 activation contributes to tumor cell growth and proliferation in human hepatocellular carcinoma HepG2 and SMMC7721 cells.
Gao J; Dong Y; Zhang B; Xiong Y; Xu W; Cheng Y; Dai M; Yu Z; Xu H; Zheng G
Int J Oncol; 2012 Nov; 41(5):1773-81. PubMed ID: 22922832
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth.
Senturk S; Mumcuoglu M; Gursoy-Yuzugullu O; Cingoz B; Akcali KC; Ozturk M
Hepatology; 2010 Sep; 52(3):966-74. PubMed ID: 20583212
[TBL] [Abstract][Full Text] [Related]
12. Role of Akt inhibition on Notch1 expression in hepatocellular carcinoma: potential role for dual targeted therapy.
Sokolowski KM; Balamurugan M; Kunnimalaiyaan S; Wilson J; Gamblin TC; Kunnimalaiyaan M
Am J Surg; 2016 Apr; 211(4):755-60. PubMed ID: 26850133
[TBL] [Abstract][Full Text] [Related]
13. Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma.
Sun Q; Wang R; Wang Y; Luo J; Wang P; Cheng B
Oncol Rep; 2014 Feb; 31(2):933-9. PubMed ID: 24336972
[TBL] [Abstract][Full Text] [Related]
14. A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma.
Zhao X; Li J; He Y; Lan F; Fu L; Guo J; Zhao R; Ye Y; He M; Chong W; Chen J; Zhang L; Yang N; Xu B; Wu M; Wan D; Gu J
Cancer Res; 2001 Oct; 61(20):7383-7. PubMed ID: 11606366
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors. Synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptor.
Sutter AP; Maaser K; Höpfner M; Huether A; Schuppan D; Scherübl H
J Hepatol; 2005 Nov; 43(5):808-16. PubMed ID: 16083991
[TBL] [Abstract][Full Text] [Related]
16. Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1.
Hernández-Breijo B; Monserrat J; Román ID; González-Rodríguez Á; Fernández-Moreno MD; Lobo MV; Valverde ÁM; Gisbert JP; Guijarro LG
Toxicol Appl Pharmacol; 2013 Nov; 272(3):568-78. PubMed ID: 23958494
[TBL] [Abstract][Full Text] [Related]
17. Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells.
Höpfner M; Huether A; Sutter AP; Baradari V; Schuppan D; Scherübl H
Biochem Pharmacol; 2006 May; 71(10):1435-48. PubMed ID: 16530734
[TBL] [Abstract][Full Text] [Related]
18. Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.
Huynh H; Ngo VC; Fargnoli J; Ayers M; Soo KC; Koong HN; Thng CH; Ong HS; Chung A; Chow P; Pollock P; Byron S; Tran E
Clin Cancer Res; 2008 Oct; 14(19):6146-53. PubMed ID: 18829493
[TBL] [Abstract][Full Text] [Related]
19. Multiple mechanisms downregulate CDKN1C in human bladder cancer.
Hoffmann MJ; Florl AR; Seifert HH; Schulz WA
Int J Cancer; 2005 Apr; 114(3):406-13. PubMed ID: 15551363
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch1 expression.
Huang X; Ma J; Xu J; Su Q; Zhao J
Mol Med Rep; 2015 Mar; 11(3):2334-40. PubMed ID: 25412322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
